Literature DB >> 29527572

Variability in Quantitative DCE-MRI: Sources and Solutions.

Harrison Kim1.   

Abstract

DCE-MRI has been extensively used for diagnosis, prognosis and therapy monitoring of various diseases including cancer. However, it has been reported that the perfusion parameters measured by DCE-MRI largely vary across different research sites, preventing data comparison in multi-institutional clinical trials. Recently, novel perfusion phantoms have been developed to correct scanner-driven errors, enabling quality assurance of quantitative DCE-MRI measurement. However, the sources for the variability in quantitating perfusion parameters are not only MRI scanners but also software packages and imaging protocols set by the operators. In this manuscript, the various sources influencing the variability in quantitative DCE-MRI measurement are reviewed, and the proper solutions to minimize those are discussed.

Entities:  

Keywords:  DCE-MRI; Phantom; Pharmacokinetic analysis; Quality assurance; Quantification

Year:  2018        PMID: 29527572      PMCID: PMC5841165     

Source DB:  PubMed          Journal:  J Nat Sci        ISSN: 2377-2700


  72 in total

1.  The effect of blood inflow and B(1)-field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast-enhanced MRI.

Authors:  Caleb Roberts; Ross Little; Yvonne Watson; Sha Zhao; David L Buckley; Geoff J M Parker
Journal:  Magn Reson Med       Date:  2011-01       Impact factor: 4.668

2.  Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.

Authors:  Thomas E Yankeelov; William D Rooney; Wei Huang; Jonathan P Dyke; Xin Li; Alina Tudorica; Jing-Huei Lee; Jason A Koutcher; Charles S Springer
Journal:  NMR Biomed       Date:  2005-05       Impact factor: 4.044

3.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.

Authors:  Thomas E Yankeelov; Jeffrey J Luci; Martin Lepage; Rui Li; Laura Debusk; P Charles Lin; Ronald R Price; John C Gore
Journal:  Magn Reson Imaging       Date:  2005-05       Impact factor: 2.546

4.  Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Hyunki Kim; Karri D Folks; Lingling Guo; Jeffery C Sellers; Naomi S Fineberg; Cecil R Stockard; William E Grizzle; Donald J Buchsbaum; Desiree E Morgan; James F George; Kurt R Zinn
Journal:  Mol Imaging       Date:  2011-06       Impact factor: 4.488

Review 5.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

6.  Modification of population based arterial input function to incorporate individual variation.

Authors:  Harrison Kim
Journal:  Magn Reson Imaging       Date:  2017-09-27       Impact factor: 2.546

7.  Expiration-phase template-based motion correction of free-breathing abdominal dynamic contrast enhanced MRI.

Authors:  Zhang Li; Jeroen A W Tielbeek; Matthan W A Caan; Carl A J Puylaert; Manon L W Ziech; Chung Y Nio; Jaap Stoker; Lucas J van Vliet; Frans M Vos
Journal:  IEEE Trans Biomed Eng       Date:  2014-12-23       Impact factor: 4.538

8.  Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.

Authors:  Tobias Heye; Matthew S Davenport; Jeffrey J Horvath; Sebastian Feuerlein; Steven R Breault; Mustafa R Bashir; Elmar M Merkle; Daniel T Boll
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

9.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

10.  Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.

Authors:  Wim Ceelen; Peter Smeets; Walter Backes; Nancy Van Damme; Tom Boterberg; Pieter Demetter; Isabel Bouckenooghe; Marieke De Visschere; Marc Peeters; Piet Pattyn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-02-02       Impact factor: 7.038

View more
  18 in total

1.  Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.

Authors:  Sharon Peled; Mark Vangel; Ron Kikinis; Clare M Tempany; Fiona M Fennessy; Andrey Fedorov
Journal:  Acad Radiol       Date:  2018-11-20       Impact factor: 3.173

2.  Dynamic Contrast Enhanced Study in Multiparametric Examination of the Prostate-Can We Make Better Use of It?

Authors:  Silva Guljaš; Mirta Benšić; Zdravka Krivdić Dupan; Oliver Pavlović; Vinko Krajina; Deni Pavoković; Petra Šmit Takač; Matija Hranić; Tamer Salha
Journal:  Tomography       Date:  2022-06-09

3.  Disposable point-of-care portable perfusion phantom for quantitative DCE-MRI.

Authors:  Martin D Holland; Andres Morales; Sean Simmons; Brandon Smith; Samuel R Misko; Xiaoyu Jiang; David A Hormuth; Chase Christenson; Roy P Koomullil; Desiree E Morgan; Yufeng Li; Junzhong Xu; Thomas E Yankeelov; Harrison Kim
Journal:  Med Phys       Date:  2021-12-10       Impact factor: 4.506

4.  Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters.

Authors:  Francesco Mungai; Giovanni Battista Verrone; Luigi Bonasera; Eleonora Bicci; Michele Pietragalla; Cosimo Nardi; Valentina Berti; Lorenzo Nicola Mazzoni; Vittorio Miele
Journal:  Radiol Med       Date:  2021-06-28       Impact factor: 3.469

5.  Golden-Angle Radial Sparse Parallel (GRASP) MRI differentiates head & neck paragangliomas from schwannomas.

Authors:  T Demerath; K Blackham; C Anastasopoulos; K T Block; B Stieltjes; T Schubert
Journal:  Magn Reson Imaging       Date:  2020-04-23       Impact factor: 2.546

6.  Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma.

Authors:  Ji Hyun Lee; Gyu Sang Yoo; Young Cheol Yoon; Hee Chul Park; Hyun Su Kim
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

7.  An Anthropomorphic Digital Reference Object (DRO) for Simulation and Analysis of Breast DCE MRI Techniques.

Authors:  Leah Henze Bancroft; James Holmes; Ryan Bosca-Harasim; Jacob Johnson; Pingni Wang; Frank Korosec; Walter Block; Roberta Strigel
Journal:  Tomography       Date:  2022-04-02

8.  Portable Perfusion Phantom Offers Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Accurate Prostate Cancer Grade Stratification: A Pilot Study.

Authors:  Harrison Kim; John V Thomas; Jeffrey W Nix; Jennifer B Gordetsky; Yufeng Li; Soroush Rais-Bahrami
Journal:  Acad Radiol       Date:  2020-03-27       Impact factor: 3.173

9.  Six-dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma.

Authors:  Nan Wang; Srinivas Gaddam; Lixia Wang; Yibin Xie; Zhaoyang Fan; Wensha Yang; Richard Tuli; Simon Lo; Andrew Hendifar; Stephen Pandol; Anthony G Christodoulou; Debiao Li
Journal:  Magn Reson Med       Date:  2020-01-21       Impact factor: 4.668

10.  18F-FDG PET and DCE kinetic modeling and their correlations in primary NSCLC: first voxel-wise correlative analysis of human simultaneous [18F]FDG PET-MRI data.

Authors:  Florent L Besson; Brice Fernandez; Sylvain Faure; Olaf Mercier; Andrei Seferian; Xavier Mignard; Sacha Mussot; Cecile le Pechoux; Caroline Caramella; Angela Botticella; Antonin Levy; Florence Parent; Sophie Bulifon; David Montani; Delphine Mitilian; Elie Fadel; David Planchard; Benjamin Besse; Maria-Rosa Ghigna-Bellinzoni; Claude Comtat; Vincent Lebon; Emmanuel Durand
Journal:  EJNMMI Res       Date:  2020-07-30       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.